MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2026 International Congress

    Anticipatory Language Prediction ERPs Detect Early Neurophysiological Changes in Asymptomatic Huntington’s Disease

    A. Puig-Davi, L. Perez-Carasol, C. Franch-Marti, J. Perez-Perez, G. Olmedo-Saura, J. Rodriguez-Antiguedad, L. Bojtos, I. Ruiz-Barrio, J. Pagonabarraga, J. Kulisevsky, S. Martinez-Horta (Barcelona, Spain)

    Objective: To determine whether ERP markers of anticipatory semantic prediction and post-target integration detect early functional brain changes in asymptomatic Huntingtin gene-expansion carriers (HGEC) compared…
  • 2026 International Congress

    Proteome-Wide Association and Mendelian Randomization Analyses Identify Plasma GUSB as a Potential Biomarker for Multiple System Atrophy

    X. Wang, X. Chen, W. Luo (Hangzhou, China)

    Objective: To identify plasma protein biomarkers associated with MSA and investigate their potential causal relationships using integrative proteomic and genetic approaches. Background: Multiple System Atrophy…
  • 2026 International Congress

    Quanti-tau-PET Study of PI‑2620 Tau-PET Quantification in Progressive Supranuclear Palsy

    Y. Compta, A. Niñerola-Baizan, C. Painous, R. Tudela, A. Camara, M. Fernandez, I. Zaro, S. Rubi, P. Bibiloni, A. Perissinotti (Barcelona, Spain)

    Objective: *Establish a quantitative analysis framework for PI‑2620 tau-PET in progressive supranuclear palsy (PSP);*Compare tau-PET uptake in PSP versus control subjects;*Assess correlations with clinical variables…
  • 2026 International Congress

    Hemoglobin Levels and Non Motor Symptoms in Parkinsons Disease Patients with Modified Hoehn and Yahr Scores

    F. Hukmiyya, E. Pasmanasari, A. Wati, S. Santoso (Semarang, Indonesia)

    Objective: This study aims to explore the association between hemoglobin (Hb) levels and the severity of non motor symptoms in Parkinson’s disease as evaluated through…
  • 2026 International Congress

    Painful legs moving toes spectrum disorders – a systematic review

    J. Kungshamn, E. Jaakkola, J. Joutsa (Turku, Finland)

    Objective: To investigate the clinical characteristics of painful legs moving toes (PLMT) spectrum disorders. Background: Classic PLMT is a rare movement disorder characterized by continuous involuntary…
  • 2026 International Congress

    Disparities in Accessing MRI-Guided Focused Ultrasound (MRgFUS) and Gamma Knife for Tremor Treatment: A Retrospective Chart Review

    S. Corrick, J. Miyasaki, S. Poonja, P. Torabi, K. Yen, G. Dimapilis, T. Sankar, F. Ba (Edmonton, Canada)

    Objective: Quantitatively describe demographic disparities among patients with tremor treated with MRgFUS and GK. Background: Thalamotomy is an established and effective treatment of tremor when…
  • 2026 International Congress

    Insight into α-synuclein pathogenicity by a human cell model with suppressed NatB-mediated N-terminal acetylation

    A. Caiella, E. Timmerman, M. Lundekvam, N. Glomnes, T. Hjellvoll, F. Impens, H. Aksnes, T. Arnesen (Bergen, Norway)

    Objective: Our aim was to study α-syn Nt-acetylation and its impact on the disease-relevant properties of this protein in cell models to shed light on…
  • 2026 International Congress

    Anhedonia in Parkinson’s Disease: Prevalence and Clinical Correlations

    Z. Sayfutdinkhuzhaev, I. Zhukova, N. Zhukova, G. Isroilova (Tomsk, Russian Federation)

    Objective: To investigate the prevalence of anhedonia in patients with Parkinson’s disease (PD) and to analyze its relationship with age, motor deficit severity, depression, and…
  • 2026 International Congress

    Clinical Underestimation of Wearing-Off in Parkinson’s Disease: Patient-Reported Outcomes Versus Clinical Assessment and Impact on Quality of Life

    M. Acharya, A. Debnath (Kharagpur, India)

    Objective: To prospectively investigate the frequency and determinants of wearing-off (WO) in Parkinson's disease (PD) using a validated patient-reported instrument compared to routine neurological evaluation,…
  • 2026 International Congress

    Can digital Mobility Outcomes differentiate cognitive impairment in Parkinson’s Disease?

    P. Ginis, D. Muzyka, V. Shah, L. Alcock, C. Schlenstedt, C. Becker, J. Buekers, B. Caulfield, C. Hansen, S. Del Din, L. Delgado-Ortiz, J. Garcia-Aymerich, H. Gassner, A. Nieuwboer, J. Hausdorff, A. Mirelman, L. Rochester, W. Maetzler, A. Yarnall (Philadelphia, USA)

    Objective: To determine if digital mobility outcomes (DMOs) differentiate between those with and without cognitive impairment in Parkinson’s disease (PD). Background: Cognitive impairment is common…
  • « Previous Page
  • 1
  • …
  • 66
  • 67
  • 68
  • 69
  • 70
  • …
  • 208
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley